Literature DB >> 1281427

Structural analysis of lipooligosaccharide produced by Neisseria gonorrhoeae, strain MS11mk (variant A): a precursor for a gonococcal lipooligosaccharide associated with virulence.

D E Kerwood1, H Schneider, R Yamasaki.   

Abstract

We studied the structure of the lipooligosaccharide (LOS) that is produced by a variant A of strain MS11mk. This variant produces a single LOS that is recognized by monoclonal antibody (MAb) 2-1-L8. In a recent study of the pathogenesis of Neisseria gonorrhoeae in male volunteers, variant A gave rise to other phase variants that produce higher molecular weight LOSs, and these LOS were associated with virulence. Definition of the structure of the variant A LOS is important to understand the biosynthesis of LOS and its expression in vivo. The dephosphorylated oligosaccharide (OS) structure derived from the variant A LOS was analyzed by two-dimensional NMR and methylation analysis. The OS structure was found to be a truncated form of the LOS produced by strain F62 [Yamasaki et al. (1991) Biochemistry 30, 10566-10575]; the variant A OS is a hexamer, a beta-lactosyl residue linked to a tetrasaccharide: Gal beta 1-->4Glc beta 1-->4[GlcNAc alpha 1-->2Hep alpha 1-->3]Hep alpha 1-->KDO. We determined that the variant A LOS is a precursor for the synthesis of higher MW LOS. We also studied expression of the MAb 2-1-L8-defined epitope present on the variant A LOS. Our data indicate that the MAb-defined epitope is not a linear beta-lactosyl residue but its specificity is directed toward the phosphorylated GlcNAc-Hep-Hep residue. Since this MAb binds to gonococci, at least part of the phosphorylated diheptose area is exposed on the gonococcal surface.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281427     DOI: 10.1021/bi00166a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Authors:  Morris D Cooper; Melissa H Roberts; Ona L Barauskas; Gary A Jarvis
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

2.  The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.

Authors:  Ryohei Yamasaki; Uichirou Yabe; Chikako Kataoka; Ushio Takeda; Shunpei Asuka
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae.

Authors:  A Banerjee; R Wang; S N Uljon; P A Rice; E C Gotschlich; D C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.

Authors:  T J Inzana; J Hensley; J McQuiston; A J Lesse; A A Campagnari; S M Boyle; M A Apicella
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.

Authors:  E E Moran; B L Brandt; W D Zollinger
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Biochemical properties of Neisseria gonorrhoeae LgtE.

Authors:  Andrzej Piekarowicz; Daniel C Stein
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

Review 7.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.

Authors:  E S Drazek; D C Stein; C D Deal
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

9.  Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum.

Authors:  Lisa A Lewis; Biswa Choudhury; Jacqueline T Balthazar; Larry E Martin; Sanjay Ram; Peter A Rice; David S Stephens; Russell Carlson; William M Shafer
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

10.  Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.

Authors:  J J Kim; N J Phillips; B W Gibson; J M Griffiss; R Yamasaki
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.